Fig. 6From: A nomogram model based on pre-treatment and post-treatment MR imaging radiomics signatures: application to predict progression-free survival for nasopharyngeal carcinomaEstablished clinical nomogram and various clinical-and-radiomics nomograms according to the data before and after treatment. Nomogram A, including selected clinical risk factors of Table 2, Nomogram B, referring to add RS1 on the basis of clinical risk factors, and Nomogram C, referring to add RS2 on the basis of clinical risk factors, for one- and two-year progression-free survival in patients with NPC. Nomogram D, that was composite clinical-and-radiomics model, for one- and two-year progression-free survival in NPC patientsBack to article page